2025 SPEAKERS

Scientific Advisory Committee

Bo Ying

Chief Executive Officer

AboGen Inc.

Kevin Kee-Jong Hong

Professor

Gachon University School of Medicine, Korea mRNA Vaccine Initiative (KmVAC)

Biophama & Academic Leaders

Adam zhao

Chief Executive Officer

Anlong Bio

Hayato Watanabe

CEO

Crafton Biotechnology

Jaehyun Choi

Chief Executive Officer - Research & Development

Genexine, Inc.

June Kim

CMC Lead

CEPI

Kug Hwa Lee

Director

MediciBIO

Madhavan Nallani

CEO

ACM Biosciences

Norihiko Shiraish

Executive Officer, Chief Scientific Officer & mRNA IPG Unit Head

NANO MRNA Co., Ltd.

Pengbo Guo

Head of Product Development

CybernaX Bio

RONGKUAN HU

Founder & Chief Executive Officer

Starna therapeutics

Sang Hwan Seo

Senior Scientist - Research & Lab Manager

International Vaccine Institute (IVI)

Sara Mingdan Deng

Sara Mingdan Deng

Senior Scientist

Innorna

Sunghoon Ma

Research Early Development

GC Pharma

Wonil Kim

Chief Scientific Officer

Aston Science Inc

Xian Zeng

Chief Executive Officer & Co-Founder

Byterna Therapeutics

Xueliang Yu

Vice President

Starna Therapeutics

Yaoqi Zhou

Professor

Shenzen Bay Laboratory

Yasumasa Ohta

mRNA technology Leader

Meiji Seika Pharma

Yeong-Chan Ahn

Director - Business Development

sml biopharm

Yi Yan Yang

Distinguished Principal Scientist

A*Star Bioprocessing Technology Institute

Yu Pang

Senior Scientist

Pfizer

Solution Experts

Blaz Bakalar

Business development manager

Sartorius BIA Separations

Davide De Lucrezia

Vice President & General Manager

TriLink BioTechnologies

Joseph Whipple

Associate Director - RNA Technologies

New England Biolabs

Josephine Cheng

Senior Modality Leader - Ribonucleic Acid Therapeutics

Merck KGaA

Nelli Erwin

Global Strategic Product Manager – Downstream Chemicals & mRNA Enzymes

Merck KGaA

NIEN-CHING Han

Senior Scientist

Hongene Biotech

Shigetomo Tsujihata

General Manager

Fujifilm Corp.

Sung Jun Park

Team Lead

Hanmi Fine Chemical